Impact on Research
Finding Cures Starts Here
The Lymphoma Research Foundation (LRF) is committed to funding the most promising lymphoma researchers and advancing the understanding of the more than 100 different subtypes of lymphoma. LRF’s disease-specificity and hyper-focus on finding cures for every type of lymphoma ensure the next generation of cancer researchers dedicate their careers to studying lymphoma, and world-leading lymphoma experts collaborate and accelerate the pace of scientific discovery.
The LRF Scientific Advisory Board (SAB) is comprised of 45 world-renowned lymphoma experts, who seek out the most innovative and promising lymphoma research projects to support.
LEARN MORE
LRF remains dedicated to finding cures for lymphoma through an aggressively-funded program for researchers.
LEARN MORE
LRF global lymphoma consortia, research initiatives, and scientific workshops help to mobilize the research community, overcome systemic challenges and speed the progress by which new treatments are developed.
LEARN MOREInvesting in the Best and Brightest Researchers, Achieving Breakthroughs
LRF funds the very best science that has the greatest potential to impact patients and ensures the best and brightest researchers remain in the field.
To date, LRF has funded more than $72 million in lymphoma-specific research and has supported key breakthroughs including:
First In-Human Clinical Trial of Adoptive Immunotherapy in Follicular Lymphoma
First Publication of the Whole-Genome Sequencing of Mantle Cell Lymphoma
Identifying the Role RNA Splicing Plays in Chronic Lymphocytic Leukemia
Using Micro RNA Array to Identify Biomarkers that Play a Critical Role in Mantle Cell Lymphoma Drug Resistance and Progression
Identifying the Mechanism Behind Ibrutinib Resistance in Mantle Cell Lymphoma
“LRF had a profound impact at the beginning of my academic career, when I needed the support most. I will always be grateful to LRF for its continuous investment in supporting innovative science, clinical research and educational programs.” – Dr. Eduardo Sotomayor, LRF Scientific Advisory Board Member
Meet Our 2022 Researchers
Juan Alderuccio, MD
Miller School of Medicine of the University of Miami
Clinical Career Development Award, Peykoff Initiative Investigator
Zachary Epstein-Peterson, MD
Memorial Sloan Kettering Cancer Center
Clinical Career Development Award
Lorenzo Falchi, MD
Memorial Sloan Kettering Cancer Center
Clinical Career Development Award, Peykoff Initiative Investigator
Boyu Hu, MD
The University of Utah
Clinical Career Development Award, Health Equity Initiative
Ivan Cohen, PhD
Perelman School of Medicine, University of Pennsylvania Postdoctoral Fellowship Grant
Clarissa Corinaldesi, PhD
Columbia University
Postdoctoral Fellowship Grant, Dr. Bruce D. Cheson Fellow
Antonio Ferreira, PhD
Brigham and Women’s Hospital
Postdoctoral Fellowship Grant, Condon Family Fellow
Huan-Chang Liang, PhD
Perelman School of Medicine, University of Pennsylvania Postdoctoral Fellowship Grant
Patrick Reville, MD
The University of Texas, M.D. Anderson Cancer Center
Postdoctoral Fellowship Grant
David Russler-German, MD, PhD
Washington University School of Medicine
Postdoctoral Fellowship Grant
Ran Xu, PhD
Dana-Farber Cancer Institute
Postdoctoral Fellowship Grant, Dr. Oliver Press Memorial Fellow
Stephen Ansell, MD, PhD
Mayo Clinic, Rochester
Follicular Lymphoma Priority Research Grant, Peykoff Initiative Investigator
Todd Fehniger, MD, PhD
Washington University School of Medicine
Follicular Lymphoma Priority Research Grant, Peykoff Initiative Investigator
Abner Louissaint, MD, PhD
Massachusetts General Hospital
Follicular Lymphoma Priority Research Grant, Peykoff Initiative Investigator
David Scott, MBCHB, PhD
BC Cancer
Follicular Lymphoma Priority Research Grant, Peykoff Initiative Investigator
Hans Guido Wendel, MD
Memorial Sloan Kettering Cancer Center
Follicular Lymphoma Priority Research Grant, Peykoff Initiative Investigator
Reid Merryman, MD, MS
Dana-Farber Cancer Institute
Career Development Award
Coraline Mlynarczyk, MS, PhD
Joan & Sanford I. Weill Cornell Medical College of Cornell University
Patrizia Mondello, MD, PhD, MSc
Memorial Sloan Kettering Cancer Center
Peykoff Initiative Scholar
Erin Mulvey, MD
Weill Cornell Medicine
Peykoff Initiative Scholar
Nicole Prutsch, PhD
Dana-Farber Cancer Institute
Postdoctoral Fellowship Grant
FINDING CURES STARTS HERE
25 Years of Innovation & Progress
1995 was a significant year for the Lymphoma Research Foundation (LRF)—it was then that LRF realized its dual mission to eradicate lymphoma and to serve those touched by this disease.
Finding cures starts here. Through lymphoma-specific research grants and consortia, LRF-supported researchers have been involved in many of the most significant lymphoma breakthroughs witnessed in the past quarter-century.
